China Universal Asset Management Company’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,216
Closed -$64.6K 490
2025
Q2
$64.6K Buy
1,216
+1,000
+463% +$50.8K 0.01% 402
2025
Q1
$9.35K Hold
216
﹤0.01% 480
2024
Q4
$12.1K Hold
216
﹤0.01% 489
2024
Q3
$14.7K Hold
216
﹤0.01% 413
2024
Q2
$9.13K Hold
216
﹤0.01% 401
2024
Q1
$14.9K Hold
216
﹤0.01% 431
2023
Q4
$16K Hold
216
﹤0.01% 414
2023
Q3
$14.7K Sell
216
-6,941
-97% -$589K ﹤0.01% 317
2023
Q2
$672K Buy
7,157
+7,029
+5,491% +$548K 0.21% 98
2023
Q1
$8.68K Hold
128
﹤0.01% 309
2022
Q4
$6.34K Hold
128
﹤0.01% 266
2022
Q3
$4K Hold
128
﹤0.01% 296
2022
Q2
$5K Hold
128
﹤0.01% 91
2022
Q1
$9K Hold
128
﹤0.01% 81
2021
Q4
$10K Buy
+128
New +$11.3K ﹤0.01% 86

Other funds holding EXAS

China Universal Asset Management Company's EXAS Position: Q3 2025 in Review

China Universal Asset Management Company sold out of Exact Sciences (EXAS) in Q3 2025, closing a stake of 1,216 shares — an estimated $64.6K sold.

China Universal Asset Management Company first reported a position in EXAS in Q4 2021 and held it in 15 quarters. The position peaked at $672K in Q2 2023. 569 funds tracked by Wall St. Rank hold EXAS as of Q3 2025.

  • China Universal Asset Management Company reported no remaining Exact Sciences position as of Q3 2025 after selling out during the quarter.
  • China Universal Asset Management Company sold 1,216 Exact Sciences shares in Q3 2025, an estimated $64.6K.
  • China Universal Asset Management Company first reported a position in Exact Sciences in Q4 2021 and held it in 15 quarters.
  • China Universal Asset Management Company's Exact Sciences position peaked at $672K in Q2 2023.
  • 569 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2025.

Based on China Universal Asset Management Company's 13F filing for Q3 2025, filed 10 Nov 2025.